TIMOTHY J HENKEL
Medical Practice in Berwyn, PA

License number
Pennsylvania MD055740L
Category
Medicine
Type
Medical Physician and Surgeon
Address
Address
Berwyn, PA 19312

Personal information

See more information about TIMOTHY J HENKEL at radaris.com
Name
Address
Phone
Timothy Henkel
1113 Cymry Dr, Berwyn, PA 19312
Timothy Henkel
462 Barclay Rd, Bryn Mawr, PA 19010
Timothy Henkel
324 Kenmont Ave, Pittsburgh, PA 15216
Timothy Henkel
109 Altadena Dr, Pittsburgh, PA 15228
Timothy Henkel
377 Avon Rd, Devon, PA 19333

Organization information

See more information about TIMOTHY J HENKEL at bizstanding.com

Timothy J. Henkel, LLC

1113 Cymry Dr, Berwyn, PA 19312

Status:
Inactive
Industry:
Medical Doctor's Office
Medical Doctor, Principal:
Timothy J. Henkel Medical Doctor, Principal, inactive

Professional information

Timothy J Henkel Photo 1

Dr. Timothy J Henkel, Berwyn PA - MD (Doctor of Medicine)

Specialties:
Infectious Disease Medicine
Address:
1113 Cymry Dr, Berwyn 19312
(610) 889-1791 (Phone), (610) 889-3376 (Fax)
Certifications:
Infectious Disease, 1992, Internal Medicine, 1991
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Washington Center / School of Medicine
Graduated: 1988
Barnes Hosp-Wash U Mc
Wash U Mc


Timothy Henkel Photo 2

Stable Compositions Of Dalbavancin

US Patent:
2004022, Nov 11, 2004
Filed:
Apr 20, 2004
Appl. No.:
10/829068
Inventors:
Marco Cavaleri - Saronno, IT
Daniela Jabes - Cassina Rizzardi, IT
Timothy Henkel - Berwyn PA, US
Adriano Malabarba - Buccinasco, IT
Giorgio Mosconi - Malvern PA, US
Martin Stogniew - Blue Bell PA, US
Richard White - Emeryville CA, US
Assignee:
Vicuron Pharmaceuticals, Inc. - King of Prussia PA
International Classification:
A61K031/704
US Classification:
514/037000
Abstract:
The invention provides methods and compositions for treatment of bacterial infections. Methods of the invention include administration of dalbavancin for treatment of a bacterial infection, in particular a Gram-positive bacterial infection of skin and soft tissue. Dosing regimes include once weekly administration of dalbavancin, which often remains at therapeutic levels in the bloodstream for at least one week, providing prolonged therapeutic action against a bacterial infection.


Timothy Henkel Photo 3

Compositions And Methods For Treating Bacterial Infections With Protein-Dalbavancin Complexes

US Patent:
2005000, Jan 6, 2005
Filed:
Nov 14, 2003
Appl. No.:
10/713924
Inventors:
Marco Cavaleri - Saronno, IT
Luigi Colombo - Malnate, IT
Timothy Henkel - Berwyn PA, US
Daniela Jabes - Cassina Rizzardi, IT
Adriano Malabarba - Buccinasco, IT
Giorgio Mosconi - Malvern PA, US
Martin Stogniew - Blue Bell PA, US
Richard White - Emeryville CA, US
International Classification:
A61K038/16, C07K014/765
US Classification:
514008000, 530322000, 530395000
Abstract:
The invention provides methods and compositions for treatment of bacterial infections. Methods of the invention include administration of dalbavancin for treatment of a bacterial infection, in particular a Gram-positive bacterial infection of skin and soft tissue, under conditions where a protein-dalbavancin complex forms, or administering a protein-dalbavancin complex. Dosing regimes include once weekly administration of dalbavancin, which often remains at therapeutic levels in the bloodstream for at least one week, providing prolonged therapeutic action against a bacterial infection.


Timothy Henkel Photo 4

Methods Of Administering Dalbavancin For Treatment Of Skin And Soft Tissue Infections

US Patent:
2005003, Feb 10, 2005
Filed:
Sep 15, 2004
Appl. No.:
10/942197
Inventors:
Marco Cavaleri - Saronno, IT
Daniela Jabes - Cassina Rizzardi, IT
Timothy Henkel - Berwyn PA, US
Adriano Malabarba - Buccinasco, IT
Giorgio Mosconi - Malvern PA, US
Martin Stogniew - Blue Bell PA, US
Richard White - Emeryville CA, US
International Classification:
A61K031/704
US Classification:
514037000
Abstract:
The invention provides methods and compositions for treatment of bacterial infections. Methods of the invention include administration of dalbavancin for treatment of a bacterial infection, in particular an uncomplicated Gram-positive bacterial infection of skin and soft tissue. Dosing regimes include once weekly administration of dalbavancin, which often remains at therapeutic levels in the bloodstream for at least one week, providing prolonged therapeutic action against a bacterial infection.


Timothy Henkel Photo 5

Methods Of Administering Dalbavancin For Treatment Of Skin And Soft Tissue Infections

US Patent:
2005013, Jun 16, 2005
Filed:
Sep 15, 2004
Appl. No.:
10/942604
Inventors:
Marco Cavaleri - Saronno, IT
Daniela Jabes - Cassina Rizzardi, IT
Timothy Henkel - Berwyn PA, US
Adriano Malabarba - Buccinasco, IT
Giorgio Mosconi - Malvern PA, US
Martin Stogniew - Blue Bell PA, US
Richard White - Emeryville CA, US
International Classification:
A61K031/704
US Classification:
514035000
Abstract:
The invention provides methods and compositions for treatment of bacterial infections. Methods of the invention include administration of dalbavancin for treatment of a bacterial infection, in particular a Gram-positive bacterial complicated infection of skin and soft tissue. Dosing regimes include once weekly administration of dalbavancin, which often remains at therapeutic levels in the bloodstream for at least one week, providing prolonged therapeutic action against a bacterial infection.


Timothy Henkel Photo 6

Methods Of Administering Dalbavancin For Treatment Of Bacterial Infections

US Patent:
6900175, May 31, 2005
Filed:
Nov 14, 2003
Appl. No.:
10/714261
Inventors:
Marco Cavaleri - Saronno, IT
Daniela Jabes - Cassina Rizzardi, IT
Timothy Henkel - Berwyn PA, US
Adriano Malabarba - Buccinasco, IT
Giorgio Mosconi - Malvern PA, US
Martin Stogniew - Blue Bell PA, US
Richard J. White - Emeryville CA, US
Assignee:
Vicuron Pharmaceuticals Inc. - King of Prussia PA
International Classification:
A61K038/16
US Classification:
514 8
Abstract:
The invention provides methods and compositions for treatment of bacterial infections. Methods of the invention include administration of dalbavancin for treatment of a bacterial infection, in particular a Gram-positive bacterial infection of skin and soft tissue. Dosing regimes include once weekly administration of dalbavancin, which often remains at therapeutic levels in the bloodstream for at least one week, providing prolonged therapeutic action against a bacterial infection.


Timothy Henkel Photo 7

Stable Pharmaceutical Compositions Of Dalbavancin And Methods Of Administration

US Patent:
7115564, Oct 3, 2006
Filed:
Apr 16, 2004
Appl. No.:
10/828439
Inventors:
Marco Cavaleri - Saronno, IT
Daniela Jabes - Cassina Rizzardi, IT
Timothy Henkel - Berwyn PA, US
Adriano Malabarba - Buccinasco, IT
Giorgio Mosconi - Malvern PA, US
Martin Stogniew - Blue Bell PA, US
Richard J. White - Emeryville CA, US
Assignee:
Vicuron Pharmaceuticals, Inc. - King of Prussia PA
International Classification:
A61K 38/16
US Classification:
514 8, 530322
Abstract:
The invention provides methods and compositions for treatment of bacterial infections. Methods of the invention include administration of dalbavancin for treatment of a bacterial infection, in particular a Gram-positive bacterial infection of skin and soft tissue. Dosing regimes include once weekly administration of dalbavancin, which often remains at therapeutic levels in the bloodstream for at least one week, providing prolonged therapeutic action against a bacterial infection.


Timothy Henkel Photo 8

Methods Of Administering Dalbavancin For Treatment Of Bacterial Infections

US Patent:
2009029, Dec 3, 2009
Filed:
May 28, 2009
Appl. No.:
12/473390
Inventors:
Marco CAVALERI - Saronno, IT
Daniela JABES - Cassina Rizzardi, IT
Timothy HENKEL - Berwyn PA, US
Adriano MALABARBA - Buccinasco, IT
Giorgio MOSCONI - Malvern PA, US
Martin STOGNIEW - Blue Bell PA, US
Richard J. WHITE - Emeryville CA, US
International Classification:
A61K 38/16
US Classification:
514 8
Abstract:
The invention provides methods and compositions for treatment of bacterial infections. Methods of the invention include administration of dalbavancin for treatment of a bacterial infection, in particular a Gram-positive bacterial infection of skin and soft tissue. Dosing regimes include once weekly administration of dalbavancin, which often remains at therapeutic levels in the bloodstream for at least one week, providing prolonged therapeutic action against a bacterial infection.


Timothy Henkel Photo 9

Methods Of Administering Dalbavancin For Treatment Of Skin And Soft Tissue Infections

US Patent:
2004019, Oct 7, 2004
Filed:
Apr 16, 2004
Appl. No.:
10/828483
Inventors:
Marco Cavaleri - Saronno, IT
Daniela Jabes - Cassina Rizzardi, IT
Timothy Henkel - Berwyn PA, US
Adriano Malabaraba - Buccinasco, IT
Giorgio Mosconi - Malvern PA, US
Martin Stogniew - Blue Bell PA, US
Richard White - Emeryville CA, US
Assignee:
Vicuron Pharmaceuticals, Inc. - King of Prussia PA
International Classification:
A61K031/545
US Classification:
514/200000
Abstract:
The invention provides methods and compositions for treatment of bacterial infections. Methods of the invention include administration of dalbavancin for treatment of a bacterial infection, in particular a Gram-positive bacterial infection of skin and soft tissue. Dosing regimes include once weekly administration of dalbavancin, which often remains at therapeutic levels in the bloodstream for at least one week, providing prolonged therapeutic action against a bacterial infection.


Timothy Henkel Photo 10

Methods Of Administering Dalbavancin For Treatment Of Bacterial Infections

US Patent:
2004022, Nov 4, 2004
Filed:
Apr 16, 2004
Appl. No.:
10/828379
Inventors:
Marco Cavaleri - Saronno, IT
Daniela Jabes - Cassina Rizzardi, IT
Timothy Henkel - Berwyn PA, US
Adriano Malabarba - Buccinasco, IT
Giorgio Mosconi - Malvern PA, US
Martin Stogniew - Blue Bell PA, US
Richard White - Emeryville CA, US
Assignee:
Vicuron Pharmaceuticals, Inc. - King of Prussia PA
International Classification:
A61K031/704
US Classification:
514/037000
Abstract:
The invention provides methods and compositions for treatment of bacterial infections. Methods of the invention include administration of dalbavancin for treatment of a bacterial infection, in particular a Gram-positive bacterial infection of skin and soft tissue. Dosing regimes include once weekly administration of dalbavancin, which often remains at therapeutic levels in the bloodstream for at least one week, providing prolonged therapeutic action against a bacterial infection.